GTR 115987889

Tenders Are Invited For Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From September 1St, 2026 To Usually August 31St, 2028

ICB — International Competitive Bid Closes Aug 07, 2026 — 6 days left Western Europe
Tender Information
GTR Reference
115987889
Tendering Authority
Subscribe to view
Tender No
505353-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From September 1St, 2026 To Usually August 31St, 2028
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union,G20
Last Date of Bid Submission
07-08-2026 6 days left
Work Detail
Pharmaceutical Products – Conclusion Of A Non-Exclusive Discount Agreement According To Section 130A Paragraph 8 Or 130C Paragraph 1 Sgb V For The Period From September 1St, 2026 To Usually August 31St, 2028. Active Ingredient Aripiprazole; Atc Code N05ax12; Dosage Form Dfl, Fer, Dis, Pld; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Botulinum Toxin; Atc Code M03ax01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Iron Maltol; Atc Code B03ab10; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Epoetin Zeta; Atc Code B03xa01; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Fondaparinux; Atc Code B01ax05; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Inclisiran Sodium; Atc Code C10ax16; Dosage Form Solution For Injection; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Lenograstim; Atc Code L03aa10; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Olanzapine; Atc Code N05ah03; Dosage Form All Except Film-Coated Tablets, Orodispersible Tablets, Tablets, Coated Tablets; Potency 2.5 Mg, 5 Mg, 7.5 Mg, 10 Mg, 15 Mg, 20 Mg; Pack Size N1, N2, N3 Each (Without Clinic Packs),Active Ingredient Perampanel; Atc Code N03ax22; Dosage Form All ; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Perindopril, Amlodipine And Indapamide; Atc Code C09bx01; Dosage Form All ; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Piribedil; Atc Code N04bc08; Dosage Form All ; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Romosozumab; Atc Code M05bx06; Dosage Form All ; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Tacrolimus; Atc Code L04ad02; Dosage Form Ret; Potency All; Pack Size All (Excluding Clinical Packs),Active Ingredient Vilanterol And Ume Clidinium Bromide; Atc Code R03al03; Dosage Form All; Potency All; Pack Size All (Excluding Clinical Packs)
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
6574d106-9278-4953-9a47-f90697fc4bff.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you

TenderDetail
Loading tenders